文献速递自身免疫性与大疱性皮肤病

钙泵、桥粒与下游信号通路:达里尔病、海利-海利病和格罗弗病的发病机制与治疗靶点

Pumping the Breaks on Acantholytic Skin Disorders: Targeting Calcium Pumps, Desmosomes, and Downstream Signaling in Darier, Hailey-Hailey, and Grover Disease.
PubMed 文献 · J Invest Dermatol · 2024-08-29

本文综述了达里尔病、海利-海利病和格罗弗病这三种棘层松解性皮肤病的分子、细胞和临床研究进展。达里尔病与海利-海利病分别由SERCA2和SPCA1钙泵突变引起,但钙稳态异常导致桥粒破坏的机制尚不清楚,格罗弗病分子基础更不明。由于机制不清,这些疾病缺乏靶向治疗,患者承受慢性水疱、感染和疼痛负担。文章旨在梳理已知知识、指出研究空白并加速新型治疗策略开发。

要点

  • 达里尔病由SERCA2突变引起,海利-海利病由SPCA1突变引起,格罗弗病病因未明。
  • 钙泵突变如何导致桥粒功能受损和棘层松解,机制仍未阐明。
  • 这三种疾病缺乏经过验证的靶向治疗,临床需求远未满足。

核心结论

  • 达里尔病、海利-海利病和格罗弗病的分子机制尚未完全阐明,导致缺乏靶向治疗,亟需明确关键发病问题以加速新疗法开发。

研究设计与样本

  • 本文为叙述性综述,回顾了达里尔病、海利-海利病和格罗弗病在分子、细胞和临床层面的已知信息,并指出知识空白和 promising 研究方向。

主要发现

  • 达里尔病由内质网钙泵SERCA2突变引起,海利-海利病由高尔基体钙/锰泵SPCA1突变引起。
  • 尽管致病突变已发现近25年,细胞内离子储存失调与质膜细胞间连接减弱之间的机制联系仍不清楚。
  • 格罗弗病的分子基础比上述两种遗传性棘层松解性疾病了解更少。
  • 由于分子病理理解不完整,这些疾病缺乏经过验证的靶向治疗选项。
  • 患者承受慢性皮肤水疱、感染和疼痛带来的显著身体和心理负担。

临床怎么用

  • 临床应认识达里尔病、海利-海利病和格罗弗病属于棘层松解性皮肤病,目前尚无靶向治疗,以对症支持为主。

局限性

  • 本文为综述,未报告原始研究数据或系统检索方法。
  • 原文未涉及具体样本量、效应量或统计学指标。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Acantholytic skin disorders, by definition, compromise intercellular adhesion between epidermal keratinocytes. The root cause of blistering in these diseases traces back to direct disruption of adhesive cell-cell junctions, exemplified by autoantibody-mediated attack on desmosomes in pemphigus. However, genetic acantholytic disorders originate from more indirect mechanisms. Darier disease and Hailey-Hailey disease arise from mutations in the endoplasmic reticulum calcium pump, SERCA2, and the Golgi calcium/manganese pump, SPCA1, respectively. Though the disease-causing mutations have been known for nearly 25 years, the mechanistic linkage between dysregulation of intracellular ion stores and weakening of cell-cell junctions at the plasma membrane remains puzzling. The molecular underpinnings of a related idiopathic disorder, Grover disease, are even less understood. Due to an incomplete understanding of acantholytic pathology at the molecular level, these disorders lack proven, targeted treatment options, leaving patients with the significant physical and psychological burdens of chronic skin blistering, infections, and pain. This article aims to review what is known at the molecular, cellular, and clinical levels regarding these under-studied disorders and to highlight knowledge gaps and promising ongoing research. Armed with this knowledge, our goal is to aid investigators in defining essential questions about disease pathogenesis and to accelerate progress toward novel therapeutic strategies.

来源:J Invest Dermatol,查看原文。版权归原作者所有。

引用

  1. Harmon RM, Ayers JL, McCarthy EF, et al. Pumping the Breaks on Acantholytic Skin Disorders: Targeting Calcium Pumps, Desmosomes, and Downstream Signaling in Darier, Hailey-Hailey, and Grover Disease. J Invest Dermatol. 2024. PMID: 39207315. doi:10.1016/j.jid.2024.06.1289

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。